These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6891594)

  • 41. Study of the bone marrow penetration of radioactivity after oral administration of radiolabelled girisopam (EGIS-5810) in mice.
    Dereszlay I; Pátfalusi M; Klebovich I
    Acta Physiol Hung; 1997-1998; 85(2):139-48. PubMed ID: 9706308
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Whole body tissue distribution of [14C]-erythromycin in the guinea pig. An autoradiographic study.
    Dette GA; Knothe H; Kellner HM
    Arzneimittelforschung; 1987 May; 37(5):524-7. PubMed ID: 3619972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Animal experimental studies on the pharmacokinetics of "essential" phospholipids (EPL)].
    Lekim D; Graf E
    Arzneimittelforschung; 1976; 26(9a):1772-82. PubMed ID: 1036713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tissue distribution and excretion of myosmine after i.v. administration to Long-Evans rats using quantitative whole-body autoradiography.
    Glas S; Tyroller S; Zwickenpflug W; Steiner K; Kiefer G; Richter E
    Arch Toxicol; 2007 Mar; 81(3):151-61. PubMed ID: 16902802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacokinetic characteristics of 14C-peritol based on data on its distribution in rat tissue].
    Dedenkov AN; Korolev GK; Kurchatova VV; Romantsova VA
    Farmakol Toksikol; 1981; 44(4):443-6. PubMed ID: 7286203
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and disposition of 14C-labelled 81/470, a new anthelminthic agent in rats.
    Paliwal JK; Ramesh D; Gupta RC
    Int J Clin Pharmacol Res; 1997; 17(1):23-30. PubMed ID: 9403350
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Absorption, distribution and excretion of 14C-putrescine in mice (author's transl)].
    Teradaira R; Fujita K; Sekiya A; Kashima M
    Radioisotopes; 1981 Mar; 30(3):140-5. PubMed ID: 7291616
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The pharmacokinetics of taurolidine metabolites in healthy volunteers.
    Gong L; Greenberg HE; Perhach JL; Waldman SA; Kraft WK
    J Clin Pharmacol; 2007 Jun; 47(6):697-703. PubMed ID: 17395893
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in-vivo.
    Ono C; Yamada M; Tanaka M
    J Pharm Pharmacol; 2003 Dec; 55(12):1647-54. PubMed ID: 14738591
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absorption, distribution and excretion of 14C-pirenzepine in rats. Accumulation characteristics after multiple dose regimen.
    Kobayashi S; Kyui S; Yoshida T; Nagakura A; Oiwa Y; Matsumura R; Kohei H
    Arzneimittelforschung; 1981; 31(4):679-90. PubMed ID: 6894697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of 14C-N-N'-dicyclopropyl-methyl-piperazine-dichlorhydrate. 1st Communication: balance of elimination, plasma and blood kinetics, metabolism in rats.
    Tufenkji AE; Campistron G; Malbosc R; Declume C; Dormard Y; Atabakhsh F; Benard P; Houin G
    Arzneimittelforschung; 1993 Mar; 43(3):323-6. PubMed ID: 8489560
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 1st communication: absorption, distribution, metabolism and excretion after topical application and subcutaneous administration in rats.
    Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Miyake T; Seki H; Inaba A
    Arzneimittelforschung; 1997 Jan; 47(1):59-69. PubMed ID: 9037446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effects and side effects of taurolin in experimental peritonitis in the rat].
    Hart H; Seifert J; Brendel W
    Langenbecks Arch Chir; 1986; 368(3):149-62. PubMed ID: 3807498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of chronic osteomyelitis with Taurolin-Gel (author's transl)].
    Götz J; Wesch G
    Z Orthop Ihre Grenzgeb; 1981 Oct; 119(5):540-3. PubMed ID: 7314830
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Drug therapy of peritonitis. 6-year experience with the chemotherapeutic agent and anti-endotoxin taurolin].
    Wesch G; Petermann C; Linder MM
    Fortschr Med; 1983 Mar; 101(12):545-50. PubMed ID: 6343207
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Taurolin gel in treatment of osteitis (author's transl)].
    Burri C; Lob G
    Aktuelle Traumatol; 1982 Jun; 12(3):159-65. PubMed ID: 6126089
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical studies on administration of taurolin in severe sepsis: a preliminary study.
    McCartney AC; Browne MK
    Prog Clin Biol Res; 1988; 272():361-71. PubMed ID: 3293082
    [No Abstract]   [Full Text] [Related]  

  • 60. AIDS and taurolin.
    Bayardelle P
    CMAJ; 1986 Mar; 134(5):476. PubMed ID: 3004686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.